# Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer

> **NCT04457570** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 600 (estimated)

## Conditions studied

- COVID, Cancer

## Interventions

- **OTHER:** mortality

## Key facts

- **NCT ID:** NCT04457570
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-15
- **Primary completion:** 2020-12-15
- **Final completion:** 2021-02-15
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04457570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04457570, "Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04457570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*